Translational Pharmacokinetic/Pharmacodynamic Analysis of MYO‐029 Antibody for Muscular Dystrophy

نویسندگان

  • P Singh
  • H Rong
  • T Gordi
  • J Bosley
  • I Bhattacharya
چکیده

Suppression of the myostatin (GDF-8) pathway has emerged as an important therapeutic paradigm for muscle-wasting disorders. In this study, we conducted a translational pharmacokinetic/pharmacodynamic (PK/PD) analysis of MYO-029, an anti-myostatin monoclonal antibody, using PK data in mice, rats, monkeys, humans, mouse tissue distribution data with 125 I-labeled MYO-029, muscle weight increase in SCID mice, and muscle circumference changes in monkeys. This analysis revealed significant in vivo potency shift between mice and monkeys (72 nM vs. 1.3 μM for 50% effect on quadriceps). Estimated central clearance of MYO-029 (0.38 mL/h/kg) in humans was greater than twofold higher than typical IgG mAbs. Peak and trough steady-state exposures of MYO-029 in patients at biweekly intravenous doses of 10 mg/kg MYO-029 are predicted to achieve only 50% and 10% of the maximum effect seen in monkeys, respectively. These retrospective analyses results suggest that the MYO-029 exposures in this trial had a low probability of producing robust efficacy.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy.

OBJECTIVE Myostatin is an endogenous negative regulator of muscle growth and a novel target for muscle diseases. We conducted a safety trial of a neutralizing antibody to myostatin, MYO-029, in adult muscular dystrophies (Becker muscular dystrophy, facioscapulohumeral dystrophy, and limb-girdle muscular dystrophy). METHODS This double-blind, placebo-controlled, multinational, randomized study...

متن کامل

The effect of immune-complex formation on the distribution of a novel antibody to the ovarian tumor antigen CA125

Pharmacokinetic and Pharmacodynamic Sciences (C.V. P., M. K., B. Q. S., P. F., L. K., J. T.), Cancer Targets (W. M.), Translational Oncology (S. C., S. R.), Pathology Labs (M. M., M. V. H.), Safety Assessment (M. S.), Assay and Automation Technology (S. P. T., G. B.). Genentech, Inc., South San Francisco, California. DMD # 34330 DMD Fast Forward. Published on September 7, 2010 as doi:10.1124/dm...

متن کامل

MRI texture analysis of GRMD dogs using orthogonal moments: A preliminary study

Magnetic resonance image texture analysis (MRI-TA) has been already demonstrated as a powerful tool to extract image information better than visual examination of grey levels. Human muscular dystrophy is a disease of which diagnosis is rather easy but it remains a lack of atraumatic methods for its follow-up as well as for the management of treatments presently in progress. MRI appears to be a ...

متن کامل

The Diagnostic Value of Utrophin in Mild Dystrophinopathy (Becker Muscular Dystrophy)

  Background and Objective: Becker Muscular Dystrophy (BMD) is a subtype of dystrophinopathies and designated as “mild form of dystrophinopathy”. The frequency rate of the disease is 1:18000 to 1:30000 in different populations and the symptoms are presented at about 8-9 years of age. The diagnostic panel composed of Serum Ceratin Kinase (SCK) measurement, Electromyography (EMG), and as a major...

متن کامل

Association of Limb-Girdle muscular dystrophy with multiple sclerosis: A case report

Background: The association of limb-girdle muscular dystrophy (LGMD) with other neurological disorders is uncommon. Case presentation: We report a 25-year-old female with LGMD who suffered from slowly progressive proximal muscular weakness and atrophy since she was 12 years of age. The patient recently presented with acute loss of left side visual acuity. After evaluation, findings were sugges...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 9  شماره 

صفحات  -

تاریخ انتشار 2016